Pembrolizumab-Associated Cardiotoxicity: A Retrospective Analysis of the FDA Adverse Events Reporting System by Stefan Milutinovic, Predrag Jancic, Vera Jokic, Marija Petrovic, Igor Dumic, Ambar Morales Rodriguez, Nikola Tanasijevic, Dustin Begosh-Mayne, Dragana Stanojevic, Ricardo O. Escarcega, Juan Lopez-Mattei, Xiangkun Cao

Connect to this object online.